Skip to content

Clinical trial of insoles for pain at the front of the knee

A randomised controlled trial to evaluate the effectiveness of insoles to treat anterior knee (patella femoral) pain

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN84641129
Enrollment
100
Registered
2008-07-31
Start date
2008-03-28
Completion date
Unknown
Last updated
2016-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anterior knee pain Musculoskeletal Diseases Anterior knee pain

Interventions

The participants will be randomly allocated to the following two arms: 1. Arm 1: Orthaheel® regular. This is a 3/4 length insole with arch shape. It is inserted into shoes and worn daily for 12 month

Sponsors

SSL International (UK)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Male or female participants between the ages of 18 and 65 years old 2. Participants with self-reported anterior knee pain (pain at the front of the knee) with a minimum of 4 weeks duration 3. Participants with self-reported anterior knee pain who score at least 40 mm on a 100 mm visual analogue scale (VAS) for pain 4. Participants with self-reported anterior knee pain in the 2 days prior to recruitment 5. Participants who agree to wear the insoles provided for at least 4 hours each day and complete diary cards and postal questionnaire as required 6. Participants who give written informed consent

Exclusion criteria

Exclusion criteria: 1. Patients must not report any acute injury to the knee at the onset of their anterior knee pain 2. Patients must not report posterior or medial/lateral knee pain or any secondary pain elsewhere in lower limb joints since the onset of anterior knee pain 3. Patients must not have any significant diagnosed musculo-skeletal disease, such as rheumatoid arthritis, diabetes or osteoarthritis of the knee or deterioration dysfunction of associated structures of the knee e.g., cartilage or any other condition associated with sensory and motor dysfunction 4. Patients must not have received or self administered treatment for the knee pain in the previous 4 weeks 5. Patients who are pregnant or breast-feeding 6. Patients who have received or self-administered treatment for the knee pain in the previous 4 weeks 7. Patients who have received corticosteroid injection therapy in the knee in the previous 3 months 8. Patients that were previously in this study 9. Patients that were in another study within the last 3 months

Design outcomes

Primary

MeasureTime frame
1. Knee pain 2. Knee function The outcomes above will be measured using the following at 4 weeks: a. VAS (scores 0-10) b. The Kujala Anterior knee pain questionnaire

Secondary

MeasureTime frame
1. Use of insoles (in time) 2. Knee pain at 3, 6 and 12 months (see primary outcome measures for methods of measurement) 3. Knee function at 3, 6 and 12 months (see primary outcome measures for methods of measurement)

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026